BDRX

Biodexa Pharmaceuticals plc

2.08

0.12+6.33%

Opening13:10 03/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.950/1.960

TODAY RANGE1.840-2.120

VOL92.47K

MARKET CAP1.39M

52 WEEK RANGE1.840-74.00

AVG VOL (3M)923.91K

% TURNOVER13.83%

TURNOVER--

P/E (TTM)-0.0136

% RANGE14.30%

EPS(TTM)-153.4413

P/E(FORWARD)-0.5386

P/B0.0027

BVPS761.49

DIVIDEND--

P/S204.31

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.27M

SHARES OUTSTANDING668.59K

NEXT EARNINGS--

FREE FLOAT609.59K

LOT SIZE1

EX-DIV DATE10/04/2024

News

Press Releases

Financial Reports

Profile

Latest

Popular

TipRanks·3d ago
Biodexa Pharmaceuticals Advances Phase 3 eRapa Program with FDA Approval
TipRanks·3d ago
Biodexa Pharmaceuticals announces outcome of a Type C meeting with FDA on eRapa
TipRanks·03/06 13:41
Biodexa Pharmaceuticals announces appointment of Precision for Medicine as CRO
TipRanks·02/24 13:58
Biodexa Pharmaceuticals Secures U.S. Patent for eRapa, Plans Phase 3 Study
TipRanks·02/24 13:41
Biodexa Pharmaceuticals announces allowance of U.S. patent covering eRapa
TipRanks·02/13 16:21
Biotech Alert: Searches spiking for these stocks today
TipRanks·02/13 13:59
Biodexa Pharmaceuticals to Present at Emerging Growth Conference
TipRanks·02/12 16:10
Biotech Alert: Searches spiking for these stocks today
TipRanks·02/12 12:46
Biodexa Pharmaceuticals receives Fast Track designation for eRapa
Seeking Alpha·02/10 14:57
Biodexa stock soars 76% on FDA Fast Track status for eRapa
TipRanks·02/10 13:57
Biodexa Pharmaceuticals Receives FDA Fast Track for eRapa in FAP Treatment
TipRanks·01/22 13:57
Biodexa Pharmaceuticals Enhances Leadership with New Chief Medical Officer
Seeking Alpha·01/22 13:43
Biodexa appoints Gary A. Shangold as Chief Medical Officer
NASDAQ·01/22 13:41
Biodexa Pharmaceuticals Names Gary Shangold Chief Medical Officer - Quick Facts
TipRanks·01/22 13:36
Biodexa Pharmaceuticals appoints Shangold as Chief Medical Officer

Same Industry

Name/Symbol

Change%

Price

Biodexa Pharmaceuticals plc

BDRX

+6.33%

2.08

Regeneron Pharmaceuticals

REGN

-1.07%

682.13

Entero Therapeutics

ENTO

-5.55%

0.4711

BIONTECH

BNTX

-1.17%

99.14

United Therapeutics Corp.

UTHR

-0.96%

304.16

Vertex Pharmaceuticals Inc

VRTX

+1.14%

501.07

Siga Technologie

SIGA

-8.51%

5.48

Moderna

MRNA

-1.13%

34.62

Charles Riv Labs Intl Inc

CRL

-0.39%

169.92

Medpace Holdings

MEDP

-0.78%

322.38

Talphera Inc

TLPH

+8.27%

0.5969

ICON PLC

ICLR

-2.12%

179.51

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-1.84%

182.00

MOLECULAR PARTNERS AG

MOLN

-0.45%

4.40

Arcturus Therape

ARCT

-3.61%

13.74

Gilead Sciences Inc

GILD

-0.82%

113.05

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

+0.04%

67.76

Aptevo Therapeutics Inc

APVO

-1.92%

2.35

Biospecifics

BSTC

0.00%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.